Presentation and surgical intervention for inflammatory myofibroblastic tumor resection of the bladder: case report
DOI:
https://doi.org/10.37497/JMRReview.v1i1.6Keywords:
Urology, Inflammatory Myofibroblastic Tumor, Benign Bladder Neoplasm, DiagnosisAbstract
Background: Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm of little known etiology, originating from visceral tissue and soft tissues, which can occur in any area of the body. In the genito-urinary system, it mainly affects the bladder, and may present with hematuria, frequency, dysuria and, more rarely, fever and weight loss. Differential diagnosis by histopathology is essential to determine whether the treatment will be radical or conservative, with partial cystectomy or transurethral resection (TURP) being the first choice for these cases. Case Report: This was a 50-year-old female patient treated at the Urology Service of the Hospital Universitário São Francisco na Providência de Deus – HUSF with complaints of hematuria for one month, suprapubic pain and urge incontinence. A computed tomography scan of the patient's abdomen and pelvis showed a urinary bladder with normal contours and morphology, however, with heterogeneous content due to the presence of an amorphous, endophytic formation, which occupied about one sixth of the organ's volume and with attenuation of hematic tissue.
Based on the findings, it was recommended that the patient undergo a transurethral bladder resection for biopsy. After that, it was then indicated an open resection of the lesion due to its extensive size. The procedure was uneventful, and a complete resection of the lesion, which had a polypoid appearance, was possible.
Conclusion: The case presented is a classic example of urinary bladder IMT.
References
CAMELA, F. et al. Pulmonary Inflammatory Myofibroblastic Tumor in Children: A Case Report and Brief Review of Literature. Frontiers in Pediatrics, v. 6, p. 35, 2018. DOI: https://doi.org/10.3389/fped.2018.00035
CESSNA, M. H. et al. Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc, v. 15, n. 9, p. 931–938, set. 2002. DOI: https://doi.org/10.1097/01.MP.0000026615.04130.1F
CHEN, C. Y. et al. Inflammatory Myofibroblastic Tumor of the Kidney Associated With a Renal Stone. , 2008.
CHENG, L. et al. Inflammatory myofibroblastic tumors of the genitourinary tract--single entity or continuum? The Journal of Urology, v. 180, n. 4, p. 1235–1240, out. 2008. DOI: https://doi.org/10.1016/j.juro.2008.06.049
COLLIN, M. et al. Inflammatory myofibroblastic tumour of the bladder in children: a review. Journal of Pediatric Urology, v. 11, n. 5, p. 239–245, out. 2015. DOI: https://doi.org/10.1016/j.jpurol.2015.03.009
COSTA, M. L. V. et al. Pseudotumor inflamatório: relato de caso. Rev Med UFC, v. 56, n. 2, p. 67–71, 2016. DOI: https://doi.org/10.20513/2447-6595.2016v56n2p67-71
DE OLIVEIRA, R. M. et al. Tumor Miofibroblástico Inflamatório. CEP, v. 30150, p. 220, 2017.
FLETCHER, S. G. et al. Regression of inflammatory pseudotumor of the bladder in a child with medical management. Urology, v. 69, n. 5, p. 982.e11–12, maio 2007. DOI: https://doi.org/10.1016/j.urology.2007.02.034
FREEMAN, A. et al. Anaplastic lymphoma kinase (ALK 1) staining and molecular analysis in inflammatory myofibroblastic tumours of the bladder: a preliminary clinicopathological study of nine cases and review of the literature. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc, v. 17, n. 7, p. 765–771, jul. 2004. DOI: https://doi.org/10.1038/modpathol.3800078
GARRIDO ABAD, P. et al. [Inflammatory myofibroblastic tumor. Case report]. Archivos Espanoles De Urologia, v. 61, n. 1, p. 62–65, fev. 2008. DOI: https://doi.org/10.4321/S0004-06142008000100008
HANSEN, C. C. et al. Maxillary sinus inflammatory myofibroblastic tumors: a review and case report. Case Reports in Oncological Medicine, v. 2015, p. 953857, 2015. DOI: https://doi.org/10.1155/2015/953857
KAPUSTA, L. R. et al. Inflammatory myofibroblastic tumors of the kidney: a clinicopathologic and immunohistochemical study of 12 cases. The American Journal of Surgical Pathology, v. 27, n. 5, p. 658–666, maio 2003. DOI: https://doi.org/10.1097/00000478-200305000-00009
KASANA, V. et al. Inflammatory Myofibroblastic Tumor of Liver Masquerading as Focal Nodular Hyperplasia in a Patient with Non-Cirrhotic Portal Hypertension and Biliary Pancreatitis. Indian Journal of Surgical Oncology, v. 7, n. 1, p. 110–114, mar. 2016. DOI: https://doi.org/10.1007/s13193-015-0381-4
KUROSAKA, S. et al. Anaplastic Lymphoma Kinase (ALK) and p53 Are Potentially Useful Markers to Distinguish Inflammatory Myofibroblastic Tumor. 2013. DOI: https://doi.org/10.4236/oju.2013.32014
LI, F. et al. Ureteral inflammatory myofibroblastic tumor: A case report and literature review. Medicine, v. 97, n. 46, p. e13177, nov. 2018. DOI: https://doi.org/10.1097/MD.0000000000013177
LI, Y.-P. et al. Inflammatory Myofibroblastic Tumor of the Urinary Bladder and Ureter in Children: Experience of a Tertiary Referral Center. Urology, v. 145, p. 229–235, nov. 2020. DOI: https://doi.org/10.1016/j.urology.2020.07.050
MONTGOMERY, E. A. et al. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. The American Journal of Surgical Pathology, v. 30, n. 12, p. 1502–1512, dez. 2006. DOI: https://doi.org/10.1097/01.pas.0000213280.35413.1b
MOSSÉ, Y. P. et al. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children’s Oncology Group Study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, v. 35, n. 28, p. 3215–3221, 1 out. 2017. DOI: https://doi.org/10.1200/JCO.2017.73.4830
ONO, A. et al. Drastic initial response and subsequent response to two ALK inhibitors in a patient with a highly aggressive ALK-rearranged inflammatory myofibroblastic tumor arising in the pleural cavity. Lung Cancer (Amsterdam, Netherlands), v. 99, p. 151–154, set. 2016. DOI: https://doi.org/10.1016/j.lungcan.2016.07.002
POTHADIYIL, A. J. et al. Inflammatory Myofibroblastic Tumor of the Kidney: A Rare Renal Tumor. Journal of clinical and diagnostic research: JCDR, v. 10, n. 11, p. ED17–ED18, nov. 2016. DOI: https://doi.org/10.7860/JCDR/2016/22465.8856
POWELL, C. L. et al. Inflammatory Myofibroblastic Tumor: A Case Study. Urology Case Reports, v. 2, n. 5, p. 173–175, set. 2014. DOI: https://doi.org/10.1016/j.eucr.2014.05.010
RAZI, A.; RADMEHR, A. Inflammatory pseudotumor of bladder: report of 2 cases and review of literature. Urology Journal, v. 5, n. 1, p. 62–65, 2008.
ROTH, J. A. Reactive pseudosarcomatous response in urinary bladder. Urology, v. 16, n. 6, p. 635–637, dez. 1980. DOI: https://doi.org/10.1016/0090-4295(80)90578-6
TSUZUKI, T.; MAGI-GALLUZZI, C.; EPSTEIN, J. I. ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder. The American Journal of Surgical Pathology, v. 28, n. 12, p. 1609–1614, dez. 2004. DOI: https://doi.org/10.1097/00000478-200412000-00009
VOELKER, H.-U. et al. Testicular Inflammatory Myofibroblastic Tumor: A Known Entity at a Very Rare Site. Case Reports in Urology, v. 2017, p. 1410843, 2017. DOI: https://doi.org/10.1155/2017/1410843
YAGHI, M. D. A case report of inflammatory myofibroblastic tumor of urinary bladder. Urology Annals, v. 8, n. 3, p. 366–368, 2016. DOI: https://doi.org/10.4103/0974-7796.184880
YAGNIK, V. et al. Inflammatory myofibroblastic tumor of the urinary bladder. Urology Annals, v. 2, n. 2, p. 78–79, maio 2010. DOI: https://doi.org/10.4103/0974-7796.65106
ZENG, X. et al. The Clinical and Radiological Characteristics of Inflammatory Myofibroblastic Tumor Occurring at Unusual Sites. BioMed Research International, v. 2018, p. 5679634, 2018. DOI: https://doi.org/10.1155/2018/5679634
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
O(s) autor(es) autoriza(m) a publicação do texto na da revista;
O(s) autor(es) garantem que a contribuição é original e inédita e que não está em processo de avaliação em outra(s) revista(s);
A revista não se responsabiliza pelas opiniões, idéias e conceitos emitidos nos textos, por serem de inteira responsabilidade de seu(s) autor(es);
É reservado aos editores o direito de proceder a ajustes textuais e de adequação às normas da publicação.
Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado (Veja O Efeito do Acesso Livre) em http://opcit.eprints.org/oacitation-biblio.html
